Annual FCF:
$239.25M+$294.18M(+535.61%)Summary
- As of today, CPRX annual free cash flow is $239.25 million, with the most recent change of +$294.18 million (+535.61%) on December 31, 2024.
- During the last 3 years, CPRX annual free cash flow has risen by +$179.90 million (+303.11%).
- CPRX annual free cash flow is now at all-time high.
Performance
CPRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$32.44M-$38.83M(-54.49%)Summary
- As of today, CPRX quarterly free cash flow is $32.44 million, with the most recent change of -$38.83 million (-54.49%) on September 30, 2025.
- Over the past year, CPRX quarterly free cash flow has dropped by -$40.17 million (-55.33%).
- CPRX quarterly free cash flow is now -55.33% below its all-time high of $72.61 million, reached on September 30, 2024.
Performance
CPRX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$234.54M-$40.17M(-14.62%)Summary
- As of today, CPRX TTM free cash flow is $234.54 million, with the most recent change of -$40.17 million (-14.62%) on September 30, 2025.
- Over the past year, CPRX TTM free cash flow has increased by +$46.52 million (+24.74%).
- CPRX TTM free cash flow is now -14.62% below its all-time high of $274.72 million, reached on June 30, 2025.
Performance
CPRX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CPRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +535.6% | -55.3% | +24.7% |
| 3Y3 Years | +303.1% | +3.6% | +175.7% |
| 5Y5 Years | +591.6% | +183.6% | +430.5% |
CPRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +535.6% | -55.3% | +121.6% | -14.6% | +527.0% |
| 5Y | 5-Year | at high | +535.6% | -55.3% | +121.6% | -14.6% | +527.0% |
| All-Time | All-Time | at high | +535.6% | -55.3% | +121.6% | -14.6% | +527.0% |
CPRX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $32.44M(-54.5%) | $234.54M(-14.6%) |
| Jun 2025 | - | $71.27M(+18.7%) | $274.72M(+2.7%) |
| Mar 2025 | - | $60.04M(-15.2%) | $267.57M(+11.8%) |
| Dec 2024 | $239.25M(+535.6%) | $70.79M(-2.5%) | $239.25M(+27.2%) |
| Sep 2024 | - | $72.61M(+13.2%) | $188.02M(+17.2%) |
| Jun 2024 | - | $64.13M(+102.1%) | $160.47M(+26.3%) |
| Mar 2024 | - | $31.73M(+62.2%) | $127.10M(+331.4%) |
| Dec 2023 | -$54.92M(-151.8%) | $19.55M(-56.6%) | -$54.92M(-59.7%) |
| Sep 2023 | - | $45.06M(+46.5%) | -$34.40M(+28.6%) |
| Jun 2023 | - | $30.75M(+120.5%) | -$48.16M(+8.7%) |
| Mar 2023 | - | -$150.30M(-475.0%) | -$52.76M(-149.8%) |
| Dec 2022 | $106.02M(+78.6%) | $40.08M(+28.0%) | $106.02M(+24.6%) |
| Sep 2022 | - | $31.30M(+19.6%) | $85.08M(+12.8%) |
| Jun 2022 | - | $26.16M(+208.6%) | $75.41M(+16.2%) |
| Mar 2022 | - | $8.48M(-55.7%) | $64.93M(+9.4%) |
| Dec 2021 | $59.35M(+31.8%) | $19.14M(-11.6%) | $59.35M(+11.3%) |
| Sep 2021 | - | $21.64M(+38.1%) | $53.32M(+23.7%) |
| Jun 2021 | - | $15.67M(+439.9%) | $43.12M(+5.9%) |
| Mar 2021 | - | $2.90M(-77.8%) | $40.71M(-9.6%) |
| Dec 2020 | $45.02M(+30.2%) | $13.11M(+14.6%) | $45.02M(+1.8%) |
| Sep 2020 | - | $11.44M(-13.8%) | $44.21M(-9.8%) |
| Jun 2020 | - | $13.27M(+83.9%) | $49.03M(-1.5%) |
| Mar 2020 | - | $7.21M(-41.3%) | $49.77M(+43.9%) |
| Dec 2019 | $34.59M(+234.1%) | $12.29M(-24.4%) | $34.59M(+148.3%) |
| Sep 2019 | - | $16.26M(+16.1%) | $13.93M(+252.1%) |
| Jun 2019 | - | $14.01M(+275.8%) | -$9.16M(+66.9%) |
| Mar 2019 | - | -$7.97M(+4.8%) | -$27.68M(-7.3%) |
| Dec 2018 | -$25.80M(-87.7%) | -$8.37M(-22.6%) | -$25.80M(-20.2%) |
| Sep 2018 | - | -$6.83M(-51.1%) | -$21.46M(-24.3%) |
| Jun 2018 | - | -$4.52M(+25.7%) | -$17.26M(-8.3%) |
| Mar 2018 | - | -$6.08M(-50.9%) | -$15.95M(-16.0%) |
| Dec 2017 | -$13.74M(+23.9%) | -$4.03M(-53.1%) | -$13.74M(+2.8%) |
| Sep 2017 | - | -$2.63M(+17.8%) | -$14.13M(+4.4%) |
| Jun 2017 | - | -$3.20M(+17.5%) | -$14.78M(+7.7%) |
| Mar 2017 | - | -$3.88M(+12.2%) | -$16.01M(+11.4%) |
| Dec 2016 | -$18.06M(-0.1%) | -$4.42M(-34.8%) | -$18.06M(+1.2%) |
| Sep 2016 | - | -$3.28M(+26.0%) | -$18.27M(+10.2%) |
| Jun 2016 | - | -$4.43M(+25.3%) | -$20.35M(-0.9%) |
| Mar 2016 | - | -$5.93M(-28.0%) | -$20.17M(-11.8%) |
| Dec 2015 | -$18.04M | -$4.63M(+13.6%) | -$18.04M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$5.36M(-26.2%) | -$17.40M(-11.5%) |
| Jun 2015 | - | -$4.25M(-11.7%) | -$15.61M(-8.7%) |
| Mar 2015 | - | -$3.80M(+4.8%) | -$14.36M(-10.5%) |
| Dec 2014 | -$13.00M(-31.5%) | -$3.99M(-12.0%) | -$13.00M(+1.0%) |
| Sep 2014 | - | -$3.57M(-19.0%) | -$13.14M(-16.7%) |
| Jun 2014 | - | -$3.00M(-22.7%) | -$11.25M(-11.8%) |
| Mar 2014 | - | -$2.44M(+40.9%) | -$10.07M(-1.9%) |
| Dec 2013 | -$9.89M(-90.4%) | -$4.13M(-145.3%) | -$9.89M(-33.7%) |
| Sep 2013 | - | -$1.68M(+7.1%) | -$7.39M(-8.6%) |
| Jun 2013 | - | -$1.81M(+19.8%) | -$6.81M(-10.8%) |
| Mar 2013 | - | -$2.26M(-37.8%) | -$6.15M(-18.3%) |
| Dec 2012 | -$5.19M(-4.1%) | -$1.64M(-48.9%) | -$5.19M(-4.0%) |
| Sep 2012 | - | -$1.10M(+4.0%) | -$4.99M(+2.9%) |
| Jun 2012 | - | -$1.15M(+12.2%) | -$5.15M(+5.8%) |
| Mar 2012 | - | -$1.31M(+9.3%) | -$5.46M(-9.5%) |
| Dec 2011 | -$4.99M(-32.7%) | -$1.44M(-15.0%) | -$4.99M(-15.5%) |
| Sep 2011 | - | -$1.25M(+14.5%) | -$4.32M(-11.2%) |
| Jun 2011 | - | -$1.46M(-76.3%) | -$3.89M(-8.8%) |
| Mar 2011 | - | -$831.10K(-7.6%) | -$3.57M(+5.1%) |
| Dec 2010 | -$3.76M(+51.1%) | -$772.10K(+5.5%) | -$3.76M(+1.5%) |
| Sep 2010 | - | -$817.30K(+28.9%) | -$3.82M(+12.3%) |
| Jun 2010 | - | -$1.15M(-12.5%) | -$4.36M(+25.8%) |
| Mar 2010 | - | -$1.02M(-22.9%) | -$5.87M(+23.6%) |
| Dec 2009 | -$7.69M(+7.0%) | -$831.20K(+38.6%) | -$7.69M(+21.2%) |
| Sep 2009 | - | -$1.35M(+49.2%) | -$9.75M(+10.7%) |
| Jun 2009 | - | -$2.66M(+6.1%) | -$10.92M(-10.6%) |
| Mar 2009 | - | -$2.84M(+2.2%) | -$9.87M(-19.5%) |
| Dec 2008 | -$8.26M(-84.0%) | -$2.90M(-15.1%) | -$8.26M(-31.1%) |
| Sep 2008 | - | -$2.52M(-56.0%) | -$6.30M(-40.2%) |
| Jun 2008 | - | -$1.62M(-31.8%) | -$4.50M(-3.5%) |
| Mar 2008 | - | -$1.23M(-30.0%) | -$4.35M(+3.2%) |
| Dec 2007 | -$4.49M(-274.4%) | -$942.20K(-32.0%) | -$4.49M(-6.2%) |
| Sep 2007 | - | -$714.00K(+51.3%) | -$4.23M(-17.8%) |
| Jun 2007 | - | -$1.46M(-6.9%) | -$3.59M(-69.0%) |
| Mar 2007 | - | -$1.37M(-101.8%) | -$2.12M(-182.0%) |
| Dec 2006 | -$1.20M(-161.2%) | -$678.90K(-819.9%) | -$752.70K(-919.9%) |
| Sep 2006 | - | -$73.80K | -$73.80K |
| Dec 2005 | -$459.30K(-97.7%) | - | - |
| Dec 2004 | -$232.30K(+36.5%) | - | - |
| Dec 2003 | -$365.80K | - | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of CPRX is $239.25M
What is the all-time high annual free cash flow for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual free cash flow is $239.25M
What is Catalyst Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, CPRX annual free cash flow has changed by +$294.18M (+535.61%)
What is Catalyst Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of CPRX is $32.44M
What is the all-time high quarterly free cash flow for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly free cash flow is $72.61M
What is Catalyst Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, CPRX quarterly free cash flow has changed by -$40.17M (-55.33%)
What is Catalyst Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of CPRX is $234.54M
What is the all-time high TTM free cash flow for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM free cash flow is $274.72M
What is Catalyst Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, CPRX TTM free cash flow has changed by +$46.52M (+24.74%)